Genómica con Sentido: El Enfoque Humano de las Mujeres que Lideran la NGS en América Latina

Date: March 11, 2026 - March 11, 2026
Type: Live Webinar
Location: LATAM
Areas of Interest: Genomics

En el marco del Día Internacional de la Mujer, este webinar presentará la trayectoria académica y profesional de la Dra. Carmen Alaez, reconocida líder en el campo de la genómica en América Latina. La sesión abordará los desafíos asociados a la implementación de metodologías avanzadas en el laboratorio clínico, así como el proceso de consolidación de la secuenciación de próxima generación como herramienta estratégica para el diagnóstico de enfermedades raras.

Se analizarán también los retos específicos del contexto latinoamericano, como: el acceso a tecnologías y fortalecimiento de capacidades diagnósticas, así como también estos han sido enfrentados y superados a lo largo de los años. La Dra. Alaez profundizará en estos desafíos, compartiendo una visión integral de su trayectoria en genómica del cáncer hereditario y diagnóstico molecular, así como del liderazgo femenino en el desarrollo de la medicina genómica en la región.

Ponente:
Dra. Carmen Alaez
Jefe de Departamento de Diagnóstico Genómico
INMEGEN, Mexico

Doctora en Ciencias Químicobiológicas por el IPN, es Investigadora en Ciencias Médicas “C” y Jefa del Laboratorio de Diagnóstico Genómico del INMEGEN, miembro del SNII Nivel II. Desde 2015 lidera investigaciones en genómica del cáncer y diagnóstico de enfermedades hereditarias, con enfoque en cáncer de mama y ovario, tumores sólidos, leucemia pediátrica y enfermedades mendelianas. Cuenta con 75 publicaciones, 28 capítulos de libro y cerca de 875 citas. Ha dirigido 15 tesis y ha recibido 39 premios y distinciones.

Hora:
10:00 AM (Mexico)
11:00 AM (Colombia)
1:00 PM (Brazil / Argentina)

Register

Email

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Institution(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone(Required)

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

CAPTCHA

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expresseda during this presentation are those of the speakers and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services